Great f.y.i. Get hooked here!
Local, national & international business news and events.
SOMERSET, N.J. — (BUSINESS WIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that the Committee for Medicinal Products for
Findings Presented in World Conference on Lung Cancer 2020 Presidential Symposium and Published in the Journal of Clinical Oncology KENILWORTH, N.J. — (BUSINESS WIRE) — $MRK #MRK— Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced first-time data
The online broker raised $1 billion to prop itself up. Overcoming customer anger may be harder. — NYT: Top Stories
MORRISTOWN, N.J. — (BUSINESS WIRE) — #ITPprocesses–Advanced Systems Concepts Inc. (ASCI), creators of industry-leading workflow automation software ActiveBatch, today announced that JSCAPE, a managed file transfer (MFT) leader, has been acquired. It will become an important part of ASCI’s product portfolio. JSCAPE
A dramatic crash left a hole in the hull of a high-tech America’s Cup yacht. But a round-the-clock repair effort has brought the boat back from the dead. — NYT: Top Stories
FORT LEE, N.J. — (BUSINESS WIRE) — #ESXi–ScaleMP™, a leading provider of virtualization for high-end computing, today announced that its vSMP MemoryONE has attained VMware Partner Ready for vSphere validation. By validating vSMP MemoryONE 10.0 with VMware vSphere® 7.0, and attaining the
Located in the only Cable Landing Station Colocation Campus in the United States, new PoP will expand access to high-speed IP transit WALL, N.J. & FREMONT, Calif. — (BUSINESS WIRE) — Hurricane Electric, the world’s largest IPv6-native Internet backbone, announced today that
NICE Actimize receives Regulation Asia’s Excellence Award for innovation in artificial intelligence and analytics to spot market abuse, conduct risk and suspicious communications HOBOKEN, N.J. — (BUSINESS WIRE) — NICE Actimize, a NICE (Nasdaq: NICE) business, announced today that its Holistic Trade and
KEYTRUDA Is First Checkpoint Inhibitor Approved in Europe to Treat MSI-H or dMMR Colorectal Cancer European Approval Based on Results From KEYNOTE-177 Trial Demonstrating KEYTRUDA Significantly Reduced Risk of Disease Progression or Death by 40% Compared With Chemotherapy KENILWORTH, N.J. — (BUSINESS